For example, in the treatment of Alzheimers diseases (AD) and Parkinsons diseases (PD), GLP-1RAs have shown potential in slowing disease progression, while their anti-inflammatory properties offer new hope for conditions such as osteoarthritis (OA), rheumatoid arthritis (RA) and cardiovascular diseases.13,14,15 By integrating the latest clinical trial data, we explore the efficacy of GLP-1RAs in treating diseases of the nervous, cardiovascular, endocrine, and digestive systems
[Google Scholar] 57.Uenoyama R., Miyazaki M., Miyazaki T., Shigeno Y., Tokairin Y., Konno H., Yamashita T
stimulant laxatives, which make the bowel muscles contract
Whether these drugs need to be taken for life or whether they can be safely discontinued without losing all the benefits gained, and if so, how to best transition off are crucial issues, which still need to be fully understood.